|
Fecal bile acids and neutral sterols in minipigs treated with G. lucidum and lovastatin (nmol/g dry feces) |
|||||||
| Bile acids |
Neutral Sterols |
||||||
|
|
|||||||
| Group |
NCT |
C |
CDC |
COP-ol |
COP-3-one |
CHOL erol |
CHOL anol |
|
|
|||||||
| All pigs (D1) |
1.98 |
0.86 |
0.66a |
2.41a |
0.10a |
1.73a* |
0.96 |
| All pigs (D14) |
1.98 |
1.33 |
0.16 |
3.75 |
0.17 |
2.96 |
0.91 |
| Gl (D14) |
1.98 |
1.61 |
0.14 |
3.61 |
0.18 |
3.37 |
0.87b* |
| Gl (D29) |
1.98 |
0.81 |
0.16 |
4.44 |
0.15 |
3.15 |
1.22 |
| Lovastatin (D14) |
1.98 |
0.99 |
0.19 |
3.92 |
0.15 |
2.44 |
0.96 |
| Lovastatin (D29) |
1.98 |
1.23 |
0.18 |
3.28 |
0.16 |
2.34 |
1.14 |
|
Feces were collected on D1, 14 and 29. A quantitative fecal collection was not possible, hence results are expressed per gram of feces. Abbreviations: refer to Table 4, except, NCT, 23- Nor β cholanate 5α,7α,12α triol. A paired, 2-tailed students t-test, equal variances, evaluated effects of the high cholesterol and fat diet, between D1-14 (10 minipigs); and the effects of Gl or lovastatin between D15-29 (5 minipigs/group), indicated as follows: aD1 vs 14, for all minipigs combined (P < 0.001).bD14 vs 29 (P < 0.05). *0.05 < P < 0.1, to indicate statistical trends. | |||||||
Berger et al. Lipids in Health and Disease 2004 3:2 doi:10.1186/1476-511X-3-2 |
|||||||